BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verstegen NE, Lagerwaard FJ, Hashemi SM, Dahele M, Slotman BJ, Senan S. Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy. Journal of Thoracic Oncology 2015;10:1195-200. [DOI: 10.1097/jto.0000000000000576] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Watanabe S, Yamazaki H, Kimoto T, Shiomi H, Yamada K, Suzuki G. Potential benefit of dose‐escalated stereotactic body radiation therapy using CyberKnife for early‐stage primary lung cancer. Asia-Pac J Clncl Oncology. [DOI: 10.1111/ajco.13842] [Reference Citation Analysis]
2 Gulstene S, Ruwanpura T, Palma D, Joseph N. Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer – A Done Deal? Clinical Oncology 2022. [DOI: 10.1016/j.clon.2022.08.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tisi S, Lawrence D, Antoniou S. Management of Local Disease in NSCLC. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-08-102723-3.00166-9] [Reference Citation Analysis]
4 Zheng X, Sun Y, Ye K, Fan C, Wang X, Yang Y, Jiao R, Ge H. Stereotactic ablative radiotherapy as single treatment for early stage non-small cell lung cancer: A single institution analysis. Thorac Cancer 2021;12:899-905. [PMID: 33529496 DOI: 10.1111/1759-7714.13768] [Reference Citation Analysis]
5 Moore S, Leung B, Wu J, Ho C. Survival Outcomes of Salvage Therapy for Local and Regionally Recurrent NSCLC. JTO Clin Res Rep 2020;1:100083. [PMID: 34589962 DOI: 10.1016/j.jtocrr.2020.100083] [Reference Citation Analysis]
6 Passaro A, Addeo A, Von Garnier C, Blackhall F, Planchard D, Felip E, Dziadziuszko R, de Marinis F, Reck M, Bouchaab H, Peters S. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open. 2020;5. [PMID: 32581069 DOI: 10.1136/esmoopen-2020-000820] [Cited by in Crossref: 52] [Cited by in F6Publishing: 65] [Article Influence: 26.0] [Reference Citation Analysis]
7 Weiss E, Deng X, Mukhopadhyay N, Jan N. Effects of the recurrence pattern on patient survival following SABR for stage I lung cancer. Acta Oncol 2020;59:427-33. [PMID: 31928266 DOI: 10.1080/0284186X.2019.1711172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Brooks ED, Verma V, Senan S, De Baere T, Lu S, Brunelli A, Chang JY; International Association for the Study of Lung Cancer Advanced Radiation Technology Committee. Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC. J Thorac Oncol 2020;15:176-89. [PMID: 31712134 DOI: 10.1016/j.jtho.2019.10.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
9 Nezka H, Igor P, Izidor K. Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection. Radiol Oncol 2019;53:357-61. [PMID: 31553706 DOI: 10.2478/raon-2019-0032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Roy SF, Louie AV, Liberman M, Wong P, Bahig H. Pathologic response after modern radiotherapy for non-small cell lung cancer. Transl Lung Cancer Res 2019;8:S124-34. [PMID: 31673516 DOI: 10.21037/tlcr.2019.09.05] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Kumar SS, McGarry RC. Management of local recurrences and regional failure in early stage non-small cell lung cancer after stereotactic body radiation therapy. Transl Lung Cancer Res 2019;8:S213-21. [PMID: 31673526 DOI: 10.21037/tlcr.2019.09.06] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Seo YS, Kim HJ, Wu HG, Choi SM, Park S. Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age. Thorac Cancer 2019;10:1489-99. [PMID: 31124275 DOI: 10.1111/1759-7714.13103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Beasley M, Brown S, McNair H, Faivre-Finn C, Franks K, Murray L, van Herk M, Henry A. The advanced radiotherapy network (ART-NET) UK lung stereotactic ablative radiotherapy survey: national provision and a focus on image guidance. Br J Radiol 2019;92:20180988. [PMID: 30924682 DOI: 10.1259/bjr.20180988] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Matsuo Y. A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer. Technol Cancer Res Treat 2018;17:1533033818798633. [PMID: 30198413 DOI: 10.1177/1533033818798633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Brooks ED, Sun B, Feng L, Verma V, Zhao L, Gomez DR, Liao Z, Jeter M, O'Reilly M, Welsh JW, Nguyen QN, Erasmus JJ, Eapen G, Ahrar K, Antonoff MB, Hahn SM, Heymach JV, Rice DC, Chang JY. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. JAMA Netw Open 2018;1:e181390. [PMID: 30646121 DOI: 10.1001/jamanetworkopen.2018.1390] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
16 Gobbini E, Giaj Levra M. Is there a room for immune checkpoint inhibitors in early stage non-small cell lung cancer? J Thorac Dis 2018;10:S1427-37. [PMID: 29951294 DOI: 10.21037/jtd.2018.01.81] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
17 Frakulli R, Salvi F, Balestrini D, Palombarini M, Akshija I, Cammelli S, Morganti AG, Zompatori M, Frezza G. Radiological differential diagnosis between fibrosis and recurrence after stereotactic body radiation therapy (SBRT) in early stage non-small cell lung cancer (NSCLC). Transl Lung Cancer Res 2017;6:S1-7. [PMID: 29299403 DOI: 10.21037/tlcr.2017.10.01] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
18 Blyth BJ, Cole AJ, MacManus MP, Martin OA. Radiation therapy-induced metastasis: radiobiology and clinical implications. Clin Exp Metastasis 2018;35:223-36. [PMID: 29159430 DOI: 10.1007/s10585-017-9867-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
19 Weiss E, Newman B, Shah R. Differentiating Radiation Changes from Local Recurrence after SBRT for Lung Cancer: The Need for Better Decision Guidelines. IJRRT 2017;4. [DOI: 10.15406/ijrrt.2017.04.00106] [Reference Citation Analysis]
20 Sloth Møller D, Knap MM, Nyeng TB, Khalil AA, Holt MI, Kandi M, Hoffmann L. Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer. Acta Oncol 2017;56:1604-9. [PMID: 28885090 DOI: 10.1080/0284186X.2017.1373848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
21 Van Breussegem A, Hendriks JM, Lauwers P, Van Schil PE. Salvage surgery after high-dose radiotherapy. J Thorac Dis 2017;9:S193-200. [PMID: 28446984 DOI: 10.21037/jtd.2017.03.88] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
22 Sun B, Brooks ED, Komaki RU, Liao Z, Jeter MD, McAleer MF, Allen PK, Balter PA, Welsh JD, O'Reilly MS, Gomez D, Hahn SM, Roth JA, Mehran RJ, Heymach JV, Chang JY. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial. Cancer 2017;123:3031-9. [PMID: 28346656 DOI: 10.1002/cncr.30693] [Cited by in Crossref: 78] [Cited by in F6Publishing: 98] [Article Influence: 15.6] [Reference Citation Analysis]
23 Verstegen NE, Maat AP, Lagerwaard FJ, Paul MA, Versteegh MI, Joosten JJ, Lastdrager W, Smit EF, Slotman BJ, Nuyttens JJ, Senan S. Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer. Radiat Oncol 2016;11:131. [PMID: 27716240 DOI: 10.1186/s13014-016-0706-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
24 Baker S, Dahele M, Lagerwaard FJ, Senan S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol 2016;11:115. [PMID: 27600665 DOI: 10.1186/s13014-016-0693-8] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 14.8] [Reference Citation Analysis]